XIIlab Co.,Ltd (KOSDAQ:189330)
South Korea · Delayed Price · Currency is KRW 8,720.00
-30.00 (-0.34%)
At close: Jun 18, 2026
XIIlab Co.,Ltd Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 10,600 | 10,272 | 9,093 | 3,663 | 9,897 | 5,778 |
Other Revenue | 0 | -0 | - | -0 | - | -0 |
| 10,600 | 10,272 | 9,093 | 3,663 | 9,897 | 5,778 | |
Revenue Growth (YoY) | 39.70% | 12.96% | 148.22% | -62.98% | 71.29% | - |
Cost of Revenue | 8,219 | 7,828 | 7,783 | 3,475 | 9,424 | 4,402 |
Gross Profit | 2,381 | 2,444 | 1,310 | 188.18 | 473.2 | 1,376 |
Selling, General & Admin | 3,444 | 2,978 | 3,073 | 2,805 | 2,726 | 1,783 |
Research & Development | 2,709 | 2,385 | 3,207 | 3,901 | 2,250 | 1,352 |
Amortization of Goodwill & Intangibles | 20.04 | 18.69 | 13.22 | 8.11 | 7.12 | 5.16 |
Operating Expenses | 6,464 | 5,669 | 6,595 | 7,099 | 5,399 | 3,382 |
Operating Income | -4,083 | -3,225 | -5,285 | -6,911 | -4,926 | -2,006 |
Interest Expense | -41.58 | -49.87 | -81.61 | -112.74 | -145.39 | -151.53 |
Interest & Investment Income | 500.92 | 387.3 | 355.48 | 640.09 | 471.21 | 144.23 |
Earnings From Equity Investments | -425.09 | -451.54 | -200.69 | -145.78 | -75.06 | -63.84 |
Currency Exchange Gain (Loss) | -4.18 | -1.34 | 2.65 | -0.47 | - | 0.93 |
Other Non Operating Income (Expenses) | 12.19 | 37.2 | 22.21 | 67.73 | 106.36 | 192.67 |
EBT Excluding Unusual Items | -4,040 | -3,303 | -5,187 | -6,462 | -4,569 | -1,884 |
Gain (Loss) on Sale of Investments | 0.43 | 0.17 | 1.24 | 0.37 | 24.52 | 9.18 |
Gain (Loss) on Sale of Assets | - | 185.02 | - | 2.46 | - | -0.28 |
Pretax Income | -4,040 | -3,118 | -5,186 | -6,459 | -4,545 | -1,875 |
Income Tax Expense | 1.14 | 1.14 | 1.09 | - | - | 260.76 |
Net Income | -4,041 | -3,119 | -5,187 | -6,459 | -4,545 | -2,136 |
Net Income to Common | -4,041 | -3,119 | -5,187 | -6,459 | -4,545 | -2,136 |
Shares Outstanding (Basic) | 8 | 7 | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 8 | 7 | 6 | 6 | 6 | 6 |
Shares Change (YoY) | 34.01% | 20.51% | 0.32% | 0.80% | 3.75% | - |
EPS (Basic) | -494.77 | -424.67 | -851.00 | -1063.19 | -754.00 | -367.61 |
EPS (Diluted) | -494.93 | -424.67 | -851.00 | -1063.19 | -754.00 | -368.00 |
Free Cash Flow | -3,841 | -1,367 | -4,198 | -5,263 | -5,320 | 471.04 |
Free Cash Flow Per Share | -470.30 | -186.09 | -688.75 | -866.27 | -882.70 | 81.08 |
Gross Margin | 22.47% | 23.79% | 14.41% | 5.14% | 4.78% | 23.82% |
Operating Margin | -38.52% | -31.40% | -58.12% | -188.64% | -49.78% | -34.72% |
Profit Margin | -38.12% | -30.37% | -57.04% | -176.31% | -45.92% | -36.96% |
Free Cash Flow Margin | -36.24% | -13.31% | -46.16% | -143.66% | -53.76% | 8.15% |
EBITDA | -3,160 | -2,322 | -4,234 | -5,703 | -3,748 | -1,194 |
EBITDA Margin | -29.81% | -22.61% | -46.56% | -155.68% | -37.87% | -20.67% |
D&A For EBITDA | 922.54 | 903.01 | 1,051 | 1,207 | 1,178 | 812.04 |
EBIT | -4,083 | -3,225 | -5,285 | -6,911 | -4,926 | -2,006 |
EBIT Margin | -38.52% | -31.40% | -58.12% | -188.64% | -49.78% | -34.72% |
Advertising Expenses | - | 50.88 | 281.67 | 188.37 | 6.26 | 56.83 |